Supply Chain Intelligence

ORIC Pharmaceuticals, Inc. Supply Chain

ORIC supply chain intelligence for ORIC Pharmaceuticals, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ORIC ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
3Debt Items
20Related Chains

ORIC Pharmaceuticals, Inc. Suppliers

TickerNameConfidenceEvidence
CONTRACT-MANUFACTURING-ORGANIZATIONS CONTRACT-MANUFACTURING-ORGANIZATIONS 90% External expenses include: • the cost of manufacturing products for use in our preclinical studies and clinical trials, including payments to contract manufacturing organizations (CMOs) and consultants
CONTRACT-RESEARCH-ORGANIZATIONS CONTRACT-RESEARCH-ORGANIZATIONS 90% External expenses include: • payments to third parties in connection with the clinical development of our product candidates, including contract research organizations (CROs) and consultants
THIRD-PARTIES THIRD-PARTIES 85% • laboratory supplies
JNJ Johnson & Johnson 72% manufacturing facilities. We rely, and expect to continue to rely, on third parties for the manufacture of our product candidates for preclinical and clinical testing, as well as for commercial manuf…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from ORIC graph: manufacturing facilities. We rely, and expect to continue to rely, on third parties for the manufacture of our product…

ORIC Pharmaceuticals, Inc. Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% manufacturing facilities. We rely, and expect to continue to rely, on third parties for the manufacture of our product candidates for preclinical and clinical testing, as well as for commercial manuf…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from ORIC graph: manufacturing facilities. We rely, and expect to continue to rely, on third parties for the manufacture of our product…

ORIC Pharmaceuticals, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ORIC-DEBT-11586 Warrants outstanding: 0.0001 90% xbrl warrant detail from xbrl 2025-05-31.
ORIC-DEBT Debt stack $6.7M 90% Market cache reports total debt of $6.7M.
ORIC-DEBT-11587 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

ORIC Pharmaceuticals, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for ORIC Pharmaceuticals, Inc..

ORIC Pharmaceuticals, Inc. Ownership

HolderNameConfidenceEvidence
ORIC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 183 tracked holders.

ORIC Pharmaceuticals, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BNRG Brenmiller Energy Ltd 100.00 2
AZN AstraZeneca PLC 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
View ORIC supply chain intel →

Explore the full interactive supply chain map for ORIC Pharmaceuticals, Inc..

Open ORIC supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map